Back to top
more

MEDIFAST (MED)

(Delayed Data from NYSE)

$13.19 USD

13.19
141,206

+0.16 (1.23%)

Updated Aug 15, 2025 04:00 PM ET

After-Market: $13.20 +0.01 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 27% (180 out of 246)

Industry: Food - Miscellaneous

Zacks News

Zacks Equity Research

Factors to Watch Ahead of Sysco's (SYY) Q3 Earnings Release

Sysco's (SYY) third-quarter fiscal 2021 results are likely to reflect softness in International unit owing to pandemic-led lockdown in various regions. Also, product cost inflation is a concern.

Zacks Equity Research

Here's How Medifast (MED) is Placed Ahead of Q1 Earnings

Strength in the OPTAVIA lifestyle solution and coaching support system have most likely aided Medifast's (MED) first-quarter 2021 performance.

Zacks Equity Research

Altria (MO) Q1 Earnings Beat Estimates, Revenues Down Y/Y

Altria's (MO) first-quarter performance is hurt by soft cigarette shipment volumes. Nevertheless, higher pricing continue to remain an upside.

Zacks Equity Research

What's in Store for The Estee Lauder Companies (EL) Q3 Earnings

Strength in the Asia-Pacific region and solid online sales are likely to get reflected in The Estee Lauder Companies' (EL) third-quarter fiscal 2021 performance.

Zacks Equity Research

Factors to Watch Ahead of Church & Dwight (CHD) Q1 Earnings

Church & Dwight's (CHD) first-quarter 2021 results are likely to reflect gains from the pandemic-led higher at-home consumption, though high marketing costs are likely to be a burden.

Zacks Equity Research

Factors to Watch Ahead of Hershey's (HSY) Q1 Earnings Release

Hershey's (HSY) first-quarter 2021 results are likely to reflect strength in the North America segment and gains from innovation. However, softness in the International segment is a concern.

Zacks Equity Research

Factors to Watch Ahead of Pilgrim's Pride (PPC) Q1 Earnings

Pilgrim's Pride's (PPC) first-quarter 2021 results are likely to benefit from a focus on key customers, though softness in the U.S. operations has been a concern.

    Zacks Equity Research

    Factors to Watch Ahead of Kraft Heinz's (KHC) Q1 Earnings

    Kraft Heinz's (KHC) first-quarter 2021 results are likely to reflect gains from the pandemic-led higher at-home consumption and efficient pricing, though high SG&A costs are concerning.

      Zacks Equity Research

      Helen of Troy (HELE) Queued for Q4 Earnings: Factors to Note

      Helen of Troy's (HELE) fourth-quarter fiscal 2021 results are likely to reflect gains from Leadership Brands and higher online sales.

      Zacks Equity Research

      Mondelez (MDLZ) Lined Up for Q1 Earnings: Key Things to Note

      Mondelez's (MDLZ) first-quarter 2021 results are likely to reflect gains from acquisitions and saving efforts amid weakness in some emerging markets and high COVID-19 costs.

      Zacks Equity Research

      Archer Daniels (ADM) to Report Q1 Earnings: Is a Beat in Store?

      Archer Daniels' (ADM) Q1 revenues are likely to have benefited from momentum in its Nutrition segment, driven by strength in Animal and Human Nutrition businesses.

      Zacks Equity Research

      Philip Morris (PM) Q1 Earnings Beat Estimates, Revenues Up Y/Y

      Philip Morris' (PM) first-quarter performance reflects gains from favorable pricing variance as well as growth in heated tobacco shipment volumes.

      Zacks Equity Research

      The Estee Lauder Companies (EL) Looks Radiant: Here's Why

      The Estee Lauder Companies (EL) Skin Care portfolio is performing well. Also, the company is on track with cost-saving measures.

      Zacks Equity Research

      Factors Likely to Influence Boston Beer's (SAM) Q1 Earnings

      Boston Beer (SAM) is expected to have benefited from strong depletion and shipment growth as well as innovation in Q1. Also, strength in brands and its cost-saving initiatives bode well.

      Zacks Equity Research

      Kimberly-Clark (KMB) Queued for Q1 Earnings: Factors to Note

      Kimberly-Clark's (KMB) first-quarter 2021 results are likely to reflect escalated costs and softness in the K-C Professional unit, though the Consumer Tissue segment should offer some respite.

      Zacks Equity Research

      Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "

      Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.

      Zacks Equity Research

      Medifast (MED) Rallies More Than 25% in 6 Months: Here's Why

      Medifast (MED) has been benefiting from its OPTAVIA lifestyle solution and coaching support system, which is well placed given consumers' rising inclination toward health and wellness.

      Zacks Equity Research

      Why Is Medifast (MED) Down 11.9% Since Last Earnings Report?

      Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      Zacks Equity Research

      Lamb Weston's (LW) China Investment to Fuel Production Capacity

      Lamb Weston (LW) unveils plans to build a new french fry processing facility in Ulanqab, Inner Mongolia, China. Additionally, the company declares a quarterly dividend.

      Zacks Equity Research

      Nu Skin (NUS) More Than Doubles in a Year: Innovation a Driver

      Nu Skin (NUS) is optimistic about momentum in 2021, driven by impressive product pipeline, robust digital efforts along with steady improvement in customers and sales leaders.

      Zacks Equity Research

      The J.M. Smucker's (SJM) Deal With JDE Peet's to Aid Growth

      The J. M. Smucker (SJM) teams up with JDE Peet's, which is likely to support the former's Away From Home liquid coffee business.

      Zacks Equity Research

      General Mills (GIS) Q3 Earnings Lag Estimates, Sales Grow Y/Y

      General Mills' (GIS) third-quarter fiscal 2021 results reflect increased at-home demand amid the pandemic. However, high input costs are a concern.

      Zacks Equity Research

      General Mills (GIS) Strikes Deal With Sodiaal to Drive Growth

      General Mills (GIS) to offload 51% controlling interest in Yoplait S.A.S. to Sodiaal, in exchange of complete ownership of the Canadian Yoplait business.

      Zacks Equity Research

      Medifast (MED) is an Incredible Growth Stock: 3 Reasons Why

      Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.

      Zacks Equity Research

      Mondelez's (MDLZ) Grenade Buyout to Boost Snacking Portfolio

      Mondelez (MDLZ) is on track to acquire Grenade by the end of March and expand in the broader snacking and fast-growing well-being categories.